Abbott Laboratories (ABT) is in Healthcare, Medical Devices, based in United States, listed on NYSE. Market cap 171.55B USD. 52-week range 81.97 to 134.50 USD. Trailing P/E 31.8. Data as of 2026-10-09.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement ...